High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
Invest Radiol. 2008 Feb;43(2):141-4. doi: 10.1097/RLI.0b013e31815a3407.
Invest Radiol. 2008.
PMID: 18197066